Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL8007706

CNCc1ccccc1CNC.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 3/20 0.44
SLC6A3 Q01959 3/20 0.44
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
CYP3A4 P08684 1/20 0.42
RECQL P46063 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
CES1 P23141 2/20 0.41
CHIT1 Q13231 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
MCL1 Q07820 2/20 0.40
ALDH1A1 P00352 1/20 0.40
G6PD P11413 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Benzylmethylamine SCHEMBL30671659 0.85 MAPT (0.63) KDM4EMAPTCYP3A4SMN1; SMN2LMNA
SCHEMBL13136705 0.79 KEAP1 (0.48) SLC6A2SLC6A4SLC6A3KDM4EMAPT
SCHEMBL8016874 0.78 SLC6A4 (0.57) SLC6A2SLC6A4SLC6A3KDM4EMAPT
SCHEMBL31265560 0.78 SLC6A4 (0.57) SLC6A2SLC6A4SLC6A3KDM4EMAPT
SCHEMBL11468455 0.78 AKR1B1 (0.55) SLC6A2SLC6A4SLC6A3KDM4EMAPT
Hydrochloric Acid SCHEMBL11484601 0.77 AKR1B1 (0.53) SLC6A2SLC6A4SLC6A3KDM4EMAPT
SCHEMBL19567289 0.76 SLC6A4 (0.46) SLC6A2SLC6A4SLC6A3KDM4EMAPT
Trifluoroacetic Acid SCHEMBL10698406 0.75 ALDH1A1 (0.53) KDM4EMAPTLMNAALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL5073700 0.75 TAAR1 (0.70) SLC6A2SLC6A4SLC6A3CYP3A4HDAC3
SCHEMBL3400989 0.74 SLC6A4 (0.50) SLC6A2SLC6A4SLC6A3KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763016-B1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS AXYS PHARM INC (US) 2000-01-26 EP disclosed
US-5656660-A AMINE OR GUANIDINE GROUP-CONTAINING TRYPTASE INHIBITOR ARRIS PHARMACEUTICAL CORPORATION (US) 1997-08-12 US disclosed